Alpha Tau Medical社 NASDAQへ上場HekaBio2022年4月11日読了時間: 1分更新日:2024年3月19日当社パートナーであるAlpha Tau Medical社が3月29日にNASDAQ(ティッカー:DRTS)へ上場しました。Alpha Tau Medical社のアナウンスはこちらから(英語のみ)Photography courtesy of Nasdaq, Inc.
HekaBio, Japan-based Biopharma and MedTech Platform, Enters Strategic Partnership with Alfresa Holdings Corporation~ Accelerating Access to Innovative Therapies in Japan through Alfresa Group’s ‘ Total Supply Chain Service’ ~ Read the news release on...
HekaBio Welcomes Deron Wolfe as Chief Financial OfficerWe are pleased to announce that Deron Wolfe has joined HekaBio K.K. as Chief Financial Officer. Deron brings nearly three decades of...
Comments